Anil Kapoor Selected Research

Contactin 1

10/2021	Differential Expression of a Panel of Ten CNTN1-Associated Genes during Prostate Cancer Progression and the Predictive Properties of the Panel Towards Prostate Cancer Relapse.
1/2020	Contactin 1: An Important and Emerging Oncogenic Protein Promoting Cancer Progression and Metastasis.
3/2016	Neural Cell Adhesion Protein CNTN1 Promotes the Metastatic Progression of Prostate Cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anil Kapoor Research Topics

Disease

56	Renal Cell Carcinoma (Grawitz Tumor) 10/2022 - 09/2006
48	Neoplasms (Cancer) 06/2022 - 09/2004
33	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 11/2008
25	Kidney Neoplasms (Kidney Cancer) 10/2022 - 10/2003
16	Neoplasm Metastasis (Metastasis) 01/2022 - 10/2008
14	Carcinoma (Carcinomatosis) 03/2020 - 10/2008
5	Carcinogenesis 12/2019 - 11/2008
4	Lymphatic Metastasis 06/2022 - 01/2019
4	Wounds and Injuries (Trauma) 05/2021 - 08/2015
4	Disease Progression 01/2021 - 01/2010
4	Renal Insufficiency (Renal Failure) 01/2019 - 10/2012
4	Pain (Aches) 06/2016 - 06/2004
3	Thrombosis (Thrombus) 11/2021 - 09/2006
3	Hypertension (High Blood Pressure) 01/2021 - 03/2015
3	Chronic Renal Insufficiency 08/2017 - 03/2013
3	Polycystic Kidney Diseases (Polycystic Kidney Disease) 09/2014 - 12/2006
3	Autosomal Dominant Polycystic Kidney (ADPKD) 09/2014 - 12/2006
2	Inborn Genetic Diseases (Disease, Hereditary) 05/2022 - 03/2016
2	Angiomyolipoma 05/2022 - 03/2016
2	Tuberous Sclerosis (Bourneville's Disease) 05/2022 - 03/2016
2	Hemorrhage 05/2022 - 08/2012
2	Urologic Neoplasms (Urological Cancer) 12/2021 - 03/2017
2	Breast Neoplasms (Breast Cancer) 10/2021 - 07/2019
2	Frailty 09/2021 - 03/2020
2	Margins of Excision 05/2021 - 06/2017
2	Hypothermia 05/2021 - 01/2019
2	COVID-19 01/2021 - 07/2020
2	Infections 01/2021 - 10/2012
2	Urinary Bladder Neoplasms (Bladder Cancer) 04/2020 - 08/2014
2	Chronic Kidney Failure (Chronic Renal Failure) 01/2019 - 10/2011
2	Lower Urinary Tract Symptoms 09/2018 - 08/2016
2	Intraoperative Complications 01/2018 - 09/2006
2	Overactive Urinary Bladder (Overactive Bladder) 12/2016 - 04/2016
2	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 08/2016 - 07/2013
2	Postoperative Pain 06/2016 - 12/2006
2	Pyelonephritis 01/2016 - 08/2005
2	Urinary Retention 07/2013 - 10/2012

Drug/Important Bio-Agent (IBA)

9	Proteins (Proteins, Gene)FDA Link 12/2021 - 10/2009
6	Sunitinib (Sutent)FDA Link 01/2022 - 03/2017
4	Everolimus FDA Link 05/2022 - 01/2010
4	Prostate-Specific Antigen (Semenogelase)IBA 01/2020 - 10/2012
3	pembrolizumabIBA 01/2022 - 01/2020
3	AntigensIBA 10/2021 - 12/2018
3	Contactin 1IBA 10/2021 - 03/2016
3	Indicators and Reagents (Reagents)IBA 09/2021 - 10/2013
3	Biomarkers (Surrogate Marker)IBA 08/2020 - 01/2019
3	Radium-223IBA 07/2020 - 11/2016
3	AndrogensIBA 01/2018 - 11/2008
3	temsirolimus FDA Link 08/2009 - 05/2007
2	trans-sodium crocetinate (crocetin)IBA 05/2022 - 03/2016
2	MTOR InhibitorsIBA 05/2022 - 01/2008
2	NivolumabIBA 01/2022 - 01/2020
2	lenvatinibIBA 01/2022 - 01/2021
2	IpilimumabIBA 01/2022 - 01/2020
2	raf KinasesIBA 12/2021 - 09/2014
2	Vitamin D FDA LinkGeneric 08/2021 - 07/2021
2	CytokinesIBA 07/2021 - 09/2017
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 01/2019
2	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2020 - 11/2009
2	RNA (Ribonucleic Acid)IBA 01/2020 - 01/2019
2	pazopanib FDA Link 12/2018 - 03/2017
2	Monoclonal AntibodiesIBA 01/2018 - 07/2017
2	InterferonsIBA 01/2018 - 05/2007
2	EpitopesIBA 12/2017 - 09/2010
2	Thromboplastin (Tissue Factor)IBA 12/2017 - 09/2010
2	Endoplasmic Reticulum Chaperone BiPIBA 12/2017 - 09/2010
2	Heparin (Liquaemin)FDA LinkGeneric 12/2017 - 01/2015
2	AutoantibodiesIBA 12/2017 - 09/2010
2	Messenger RNA (mRNA)IBA 03/2017 - 12/2016
2	ErbB Receptors (EGF Receptor)IBA 01/2017 - 01/2017
2	Denosumab FDA Link 11/2016 - 04/2011
2	Docetaxel (Taxotere)FDA Link 11/2016 - 04/2011
2	Cadherins (E-Cadherin)IBA 03/2016 - 06/2012
2	TOR Serine-Threonine KinasesIBA 08/2009 - 01/2008
2	Tumor Suppressor Protein p14ARF (p14ARF)IBA 11/2008 - 09/2004
2	DiureticsIBA 08/2008 - 06/2004
2	gulonolactoneIBA 07/2007 - 09/2005
2	Oxidoreductases (Dehydrogenase)IBA 07/2007 - 09/2005
2	Ascorbic Acid (Vitamin C)FDA LinkGeneric 07/2007 - 09/2005

Therapy/Procedure

51	Nephrectomy 10/2022 - 10/2003
40	Therapeutics 10/2022 - 05/2007
19	Castration 10/2021 - 04/2011
13	Nephroureterectomy 03/2020 - 04/2012
6	Radiotherapy 07/2022 - 12/2018
5	Drug Therapy (Chemotherapy) 12/2021 - 08/2014
4	Immunotherapy 07/2022 - 01/2020
4	Length of Stay 01/2021 - 12/2006
3	Radiofrequency Ablation 10/2022 - 08/2012
3	Conservative Treatment 07/2020 - 04/2016
3	Lymph Node Excision (Lymph Node Dissection) 10/2019 - 04/2012
3	Kidney Transplantation 01/2019 - 01/2008
3	Adjuvant Chemotherapy 07/2015 - 01/2014
2	Prostatectomy (Retropubic Prostatectomy) 01/2022 - 03/2016
2	Cystectomy 04/2020 - 06/2016
2	Aftercare (After-Treatment) 08/2018 - 12/2017
2	Molecular Targeted Therapy 01/2018 - 09/2009
2	Warm Ischemia 08/2017 - 08/2012
2	Implanted Electrodes 12/2016 - 04/2016
2	Operative Time 06/2016 - 08/2015
2	Cryosurgery 12/2013 - 08/2012